Skip to main content
UNIVERSAL BIOSENSORS INC. logo

UNIVERSAL BIOSENSORS INC. — Investor Relations & Filings

Ticker · UBI ISIN · AU000000UBI2 LEI · 9845006ABC71C514C696 ASX Manufacturing
Open in API
Filings indexed 958 across all filing types
Latest filing 2025-08-21 Delisting Announcement
Country AU Australia
Listing ASX UBI

About UNIVERSAL BIOSENSORS INC.

https://universalbiosensors.com/

Universal Biosensors Inc. specializes in the research, development, and manufacture of electrochemical biosensor systems for point-of-care testing. The company leverages a proprietary technology platform to deliver rapid, accurate diagnostic results across various sectors, including healthcare and food and beverage. Its core product offerings include the Xprecia Prime system for coagulation monitoring and the Sentia platform, which provides automated laboratory-grade analysis for the wine industry, measuring parameters such as free sulfur dioxide, malic acid, and glucose. Universal Biosensors focuses on miniaturizing complex laboratory tests into portable, easy-to-use devices, utilizing multi-layer test strip architecture and sophisticated electrochemical detection methods to improve testing efficiency and accessibility in decentralized settings.

Recent filings

Filing Released Lang Actions
Suspension from Quotation 1 page 58.3KB
Delisting Announcement Classification · 95% confidence The document is a market announcement from the ASX regarding the immediate suspension of Universal Biosensors Inc. securities from quotation due to financial condition concerns and breach of listing rules. It is an official notice about the trading status of the company's stock, specifically a suspension announcement. It does not contain financial statements, management discussion, or detailed report content. The document length is short (1104 characters), and it is clearly an announcement rather than a full report. Therefore, it fits best under the category of Delisting Announcement (DLST), which includes official notices about stock removal or suspension from an exchange.
2025-08-21 English
Trading Halt 2 pages 223.5KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from Universal Biosensors Inc. regarding a trading halt requested pending the release of an announcement about the company's financial position and funding strategy. It is dated 20 August 2025 and is a formal request to the ASX for a trading halt. The document does not contain any financial data, detailed report, or analysis but is an announcement about a trading halt event. It is short (2353 characters) and serves as a notification rather than a report or detailed filing. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2025-08-19 English
KPMG appointed as Voluntary Administrators 1 page 1
Regulatory Filings Classification · 95% confidence The document is an ASX market announcement dated 20 August 2025 regarding the appointment of KPMG as voluntary administrators to Universal Biosensors Pty Limited. It discusses the appointment of administrators, suspension of director powers, and a statutory meeting of creditors. There is no financial data, no report attached or referenced as being published, and no mention of annual or interim reports, earnings, or other financial filings. The content is an official announcement about a corporate restructuring event (administration) and related procedural information. This fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories like Annual Report, Earnings Release, or M&A filings.
2025-08-19 English
Funding Strategy Update 2 pages 166.7KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 18 August 2025 providing an update on the company's funding strategy and a non-binding term sheet with a substantial securityholder regarding a proposed secured loan facility. It discusses the extension of the due diligence period and states that no binding commitment has been made yet. There are no financial statements or detailed financial data presented, nor is this a full report. The document is relatively short (3019 characters) and serves as an update on financing activities. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2025-08-17 English
Update on Funding Strategy 2 pages 172.1KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 7 August 2025 providing an update on the company's funding strategy. It discusses ongoing negotiations about a proposed secured loan facility and a potential entitlement offer to existing securityholders. The text focuses on financing activities, including terms of funding, due diligence extensions, and potential capital raising methods. There are no financial statements or detailed financial results presented, nor is this a full report or earnings release. The content clearly relates to updates on financing activities and capital structure changes. Therefore, the document fits best under the category 'Capital/Financing Update' (CAP). The document length is 4750 characters, which is sufficient for a substantive announcement but not a full report. Confidence is high given the clear focus on funding strategy updates and financing terms.
2025-08-06 English
Appendix 4D and Half Year Results - 30 June 2025 39 pages 684.6KB
Interim / Quarterly Report Classification · 100% confidence The document is titled as an Appendix 4D half year report lodged with the ASX, indicating it is a half-year financial report. It references the six months ended June 30, 2025, and includes detailed financial statements such as consolidated balance sheets, statements of comprehensive income, cash flows, and notes. It also includes a review report from PricewaterhouseCoopers, which is typical for interim financial reports. Furthermore, the document contains a Form 10-Q filing with the SEC, which is a quarterly report for the period ended June 30, 2025. The presence of actual financial data, management discussion, and analysis confirms this is a comprehensive interim/quarterly report rather than just an announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-08-03 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.